A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
Clinical trial NCT03201965 · COMPLETED
Trial details
- NCT number
- NCT03201965
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-05
- Primary completion
- 2020-02-14
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.